BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. Announces First Quarter 2026 Results

Progyny (PGNY)ProgynyEarnings

Reports Record First Quarter Revenue of $328.5 Million Early Selling Season Activity Reflects Robust Demand for Women's Health and Family Building Solutions Returned Value to Shareholders Through Repurchase of 8.8 Million Shares to Date Since November NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) --

Open original release

Related news

PGNYProgyny2026-04-23 17:56 EST

Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

PGNYProgyny2026-02-26 21:01 EST

Progyny, Inc. Announces Fourth Quarter 2025 Results

HSTMHealthStream2026-05-04 20:30 EST

HealthStream Announces First Quarter 2026 Results

HSTMHealthStream2026-04-21 13:25 EST

HealthStream to Host First Quarter 2026 Earnings Conference Call

TXMDTherapeuticsMD2026-05-12 20:05 EST

TherapeuticsMD Announces First Quarter 2026 Financial Results

SERASera Prognostics2026-04-22 12:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026

COOThe Cooper Companies2026-02-05 21:15 EST

CooperCompanies Announces Release Date for First Quarter 2026

TXMDTherapeuticsMD2025-05-13 20:05 EST

TherapeuticsMD Announces First Quarter 2025 Financial Results

TDOCTeladoc2026-04-29 20:05 EST

Teladoc Health Reports First Quarter 2026 Results

COOThe Cooper Companies2025-11-04 21:15 EST

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025

View all latest news

Progyny

Progyny is a fertility and family-building benefits company serving employers and their members through specialized reproductive-health services.

Recent company news

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

PGNYProgyny2026-05-11 14:57 EST

Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

PGNYProgyny2026-05-07 20:01 EST

Progyny, Inc. Announces First Quarter 2026 Results

PGNYProgyny2026-04-23 17:56 EST

Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

Stock data

Close
31.59 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States